Apogee Therapeutics, Inc.
(APGE - NASDAQ)
85,98 USD
📋 Profilo Aziendale

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications.

|